BNIP3 and non-small cell lung carcinoma: BNIP3 was recently established as part of a group of biomarkers for predicting the survival of lung AD and SCC along with other five autophagy-related genes, such as EIF4EBP1, TP63, ATIC, ERO1A, and FADD. Multivariate analysis of the gene expression datasets from large-scale databases revealed the signature, including these autophagy-related genes, as effectors of the development and prognosis of patients with NSCLC with different stages [76].